About Iovance (IOVA)
Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient’s own imm... Read more
- USD3.38
- USD3.58
- USD3.38
- USD14.23
- 2.50%
- 164M
- 5.70M
- 9.65M
- 1.2B
- 2.70
- -73.40%
Stock News
1 hour ago
Here’s what Trump needs to do if he really wants to stop Big Pharma from ripping seniors off
MarketWatch
1 hour ago
Jim Cramer analyzes Amazon, Apple earnings — calls one a buy at a discount
CNBC
2 hours ago
Netflix stock is trading at all-time high levels in unprecedented win streak
CNBC
2 hours ago
Q1 2025 Bio Rad Laboratories Inc Earnings Call
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
